EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

An in-silico survey on molecular mechanisms of antioxidative capacity, as an opportunity for cancer prevention

Nazanin Gholampour-Faroji, Aliakbar Haddad-Mashadrizeh, Samaneh Dolatabadi

Journal of Cellular Immunotherapy · 2015

DOI: 10.1016/j.jocit.2015.10.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular Immunotherapy, 2015. Verfasst von Nazanin Gholampour-Faroji und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

similarity in other species.Moreover, in-silico searching as well as literature review led to disclosed 20 cells surface specific antigen of brain tumors.Following, the results of corresponding ligands survey of detected antigens led to disclosure 200 matching ligands with various in function, structure and affinity to specific antigens.However, docking process led to disclosure SDC1 as a best ligand with capacity to binding to four different antigens with different binding affinity (Figure 2).Meanwhile, assessment the post-translational modification (PTM) of detected ligands led to disclosure that some of them are poor in PTM.In this regard, SDC1 PTM was confined only in two sites for phosphorylation without any glycosylation sites.On the other hand, our survey on therapeutic products of bacteria led to exposure a domain with ability to crossing the BBB.Finally, the assembly of the selected domains with glycine-serine linker led to generation a series of novel immunotoxins constructs.Subsequently, the products assays of these constructs showed quality in structure as well as in expression after codon optimization (Figure 3).However, among these constructs the product of DC-(G 4 S) 3 -DT-(G 4 S)3-SDC1 with the length of 462 amino acid showed the lowest immunogenicity.Taken together, the results of this study provide a series of cell death domain, specific ligands for targets antigen of tumor brain, and also a new immunotoxin for target therapy.

Zitieren

APA

Gholampour-Faroji, N., Haddad-Mashadrizeh, A., & Dolatabadi, S. (2015). An in-silico survey on molecular mechanisms of antioxidative capacity, as an opportunity for cancer prevention. Journal of Cellular Immunotherapy. https://doi.org/10.1016/j.jocit.2015.10.013

Vancouver

Gholampour-Faroji N, Haddad-Mashadrizeh A, Dolatabadi S. An in-silico survey on molecular mechanisms of antioxidative capacity, as an opportunity for cancer prevention. Journal of Cellular Immunotherapy. 2015. doi:10.1016/j.jocit.2015.10.013

BibTeX
@article{GholampourFaroji2015,
  author = {Gholampour-Faroji, Nazanin and Haddad-Mashadrizeh, Aliakbar and Dolatabadi, Samaneh},
  title = {An in-silico survey on molecular mechanisms of antioxidative capacity, as an opportunity for cancer prevention},
  journal = {Journal of Cellular Immunotherapy},
  year = {2015},
  doi = {10.1016/j.jocit.2015.10.013}
}
Kostenlos starten →